Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2006
11/30/2006US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
11/30/2006DE69735603T2 PTHrP Analogen PTHrP analogs
11/30/2006CA2613337A1 Nk-b inhibitors for the treatment of muscular dystrophy
11/30/2006CA2609446A1 Activator for peroxisome proliferator-activated receptor
11/30/2006CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/29/2006EP1726952A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
11/29/2006EP1726592A1 Dioxino derivatives and their use as dopanine agonists
11/29/2006EP1726590A1 Cycloalkanopyridine derivative
11/29/2006EP1726587A1 Benzothiazin-3-one compound and intermediate therefor
11/29/2006EP1726584A1 2-aminoquinazoline derivative
11/29/2006EP1726582A2 Compounds and methods for the inhibition of the expression of vcam-1
11/29/2006EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006EP1726313A1 Drug for preventing and treating arteriosclerosis
11/29/2006EP1726310A1 Medicine for cancer therapy
11/29/2006EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols
11/29/2006EP1480624B1 Pharmaceutical tablet
11/29/2006EP1411989A4 Methods for improving cell line activity in immunoisolation devices
11/29/2006EP1313504B1 Methods and compositions for inhibiting angiogenesis
11/29/2006EP1259223A4 Protein matrix materials, devices and methods of making and using thereof
11/29/2006EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006EP1248604B1 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
11/29/2006EP1220911B1 P-glycoproteins and uses thereof
11/29/2006EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
11/29/2006EP1196598B1 Dsp-3 dual-specificity phosphatase
11/29/2006EP1117692B1 Tie2 agonist antibodies
11/29/2006EP1114028B1 Aza-bicycles which modulate the inhibition of cell adhesion
11/29/2006EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
11/29/2006EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents
11/29/2006EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide
11/29/2006EP0738149B1 1-aminoindan derivatives and compositions thereof
11/29/2006EP0699194B1 5-ht4 receptor antagonists
11/29/2006CN1871347A Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in
11/29/2006CN1871240A Pyrrolopyrimidine thion derivatives
11/29/2006CN1871030A Method of inhibiting secretase activity
11/29/2006CN1870983A Compositions and foods for improving lipid metabolism
11/29/2006CN1869061A Peptidomimetic protease inhibitors
11/29/2006CN1868525A Medicine for retarding human senility and its prepn. method
11/29/2006CN1868487A Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn.
11/29/2006CN1868480A Methods for inhibiting cognitive deterioration in adults with down's syndrome
11/29/2006CN1868461A Tegaserod maleate oral prepn.
11/29/2006CN1868458A Controlled release composition and method of producing the same
11/29/2006CN1286976C Interferon-alpha/beta binding protein, its preparation and use
11/29/2006CN1286845C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV)
11/29/2006CN1286839C Fermentation preparation method of cell inhibitor and its crystal form
11/29/2006CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006CN1286834C Benzothiazoles compound
11/29/2006CN1286831C N-ureido-piperidines as antagonists viii for CCR-3 receptor
11/29/2006CN1286822C Pyrimidinone compounds
11/29/2006CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006CN1286812C Bispiperidines as antithrombotic agents
11/29/2006CN1286810C 2-acyl indol derivatives and their use as anti-tumour agents
11/29/2006CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy
11/29/2006CN1286523C Chinese medicinal pill of human body air activity smooth
11/29/2006CN1286515C Medicinal composition for treating cyst
11/29/2006CN1286491C Preparation for sobering use
11/29/2006CN1286469C Pharmaceutical use of isolarisiresinol
11/29/2006CN1286456C Luolai compositions useful for the treatment of type-2 synalbumin diabetes pharmaceutical application
11/29/2006CN1286455C Pharmaceutical use of 5-hydroxymethyl furfural
11/28/2006US7142910 Methods of indirectly stimulating the vagus nerve with an electrical field
11/28/2006US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
11/28/2006US7141598 Imidazole derivatives, production method thereof and use thereof
11/28/2006US7141582 Promoting the activity of glucocerebrosidease by administering a reversible competitive inhibitor such as iminosugars, e.g. calysegnines, isofagomines,N-alkyl-deoxynojirimycins; lysosomal storage disorders
11/28/2006US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006US7141576 4-quinazolineamine derivatives; antineoplastic agents; inhibitors of erb family tyrosine kinases and/or epidermal growth factor receptors
11/28/2006US7141575 Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
11/28/2006US7141574 Viral polymerase inhibitors
11/28/2006US7141573 Huntington's diseases, Alzheimer's diseases, psychological disorders
11/28/2006US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/28/2006US7141560 For use as analgesic or sedative; treating sleep disorders
11/28/2006US7141557 Lipid analogs for treating viral infections
11/28/2006US7141554 Method of treating irritable bowel syndrome
11/28/2006US7141545 Osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeutically effective level
11/28/2006US7141409 Hyaluronan synthase gene and uses thereof
11/28/2006US7141383 EDG8 receptor, its preparation and use
11/28/2006US7141365 Methods for diagnosing a mucin production associated disease condition
11/28/2006US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006CA2379786C Purine derivatives
11/28/2006CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006CA2305370C Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
11/28/2006CA2275379C Use of pramipexole in the treatment of restless legs syndrome
11/28/2006CA2222311C Use of at least one beta-adrenergic agonist as a p substance antagonist
11/28/2006CA2167525C Fungicidal methods and compositions for killing yeast and sporular microorganisms
11/28/2006CA2160444C Aroyl-piperdine derivatives
11/28/2006CA2137203C Protein kinase c inhibitors
11/23/2006WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006WO2006123817A1 Method for delivering nucleic acid and device for delivering nucleic acid
11/23/2006WO2006123726A1 Pharmaceutical composition
11/23/2006WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF
11/23/2006WO2006123639A1 Pyrimidine derivative
11/23/2006WO2006122512A1 Fusion proteins comprising protein transduction domain, auxiliary protein and bioactive protein, their production and uses
11/23/2006US20060264638 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one;
11/23/2006US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006US20060264517 Methods of reducing microbial resistance to drugs